How M.D. was paid
$7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Other | Total |
|---|---|---|---|---|
| Richard A. Miller, M.D.President and Chief Executive Officer | $36,566 | $6,989,000 | $6,000 | $7,031,566 |
| Leiv LeaChief Financial Officer | $405,948 | $2,795,600 | $6,000 | $3,207,548 |
| William B. Jones, Ph.D.Senior Vice President, Pharmaceutical Development | $360,115 | $2,795,600 | $6,000 | $3,161,715 |
What changed and why
- 36,566 dollars was paid as base salary to the CEO for fiscal 2025.
- 6,989,000 dollars was granted in option awards to the CEO for fiscal 2025.
- 7,031,566 dollars was the total compensation for the CEO in fiscal 2025.
- 0 annual performance-based bonuses were awarded to named executive officers for 2025 performance.
- 1,000,000 stock options were granted to the CEO in December 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.